Literature DB >> 26920355

Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation.

Floris H P van Velden1,2, Gerbrand M Kramer3, Virginie Frings3, Ida A Nissen3, Emma R Mulder3, Adrianus J de Langen4, Otto S Hoekstra3, Egbert F Smit4,5, Ronald Boellaard3,6.   

Abstract

PURPOSE: To assess (1) the repeatability and (2) the impact of reconstruction methods and delineation on the repeatability of 105 radiomic features in non-small-cell lung cancer (NSCLC) 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG) positron emission tomorgraphy/computed tomography (PET/CT) studies. PROCEDURES: Eleven NSCLC patients received two baseline whole-body PET/CT scans. Each scan was reconstructed twice, once using the point spread function (PSF) and once complying with the European Association for Nuclear Medicine (EANM) guidelines for tumor PET imaging. Volumes of interest (n = 19) were delineated twice, once on PET and once on CT images.
RESULTS: Sixty-three features showed an intraclass correlation coefficient ≥ 0.90 independent of delineation or reconstruction. More features were sensitive to a change in delineation than to a change in reconstruction (25 and 3 features, respectively).
CONCLUSIONS: The majority of features in NSCLC [(18)F]FDG-PET/CT studies show a high level of repeatability that is similar or better compared to simple standardized uptake value measures.

Entities:  

Keywords:  Non-small-cell lung cancer (NSCLC); PET/CT; Radiomics; Repeatability; Tracer uptake heterogeneity

Mesh:

Substances:

Year:  2016        PMID: 26920355      PMCID: PMC5010602          DOI: 10.1007/s11307-016-0940-2

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


Introduction

Lung cancer is the leading cause of cancer death, with more than 1.6 million deaths worldwide in 2012 [1]. About 80–85 % of the cases are classified as non-small-cell lung cancer (NSCLC) [2]. Early assessment of response to treatment (e.g., radiotherapy and/or chemotherapy) is essential to determine which patients will benefit from treatment and which may require treatment adaptations, paving the way for personalized cancer therapies [3]. Several studies have demonstrated the potential of positron emission tomography/computed tomography (PET/CT) to assess the effects of treatment for NSCLC patients early using 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) [4-7]. Although the benefits of new response metrics such as the metabolically active tumor volume (MATV) and total lesion glycolysis (TLG) are currently under investigation, response to treatment is predominantly measured using the maximum standardized uptake value (SUVmax) obtained within a tumor [8]. However, SUVmax is not capable to capture all forms of responses accurately. For instance, SUVmax can only measure response accurately if there is a global change in tracer uptake, i.e., in absence of a spatially heterogeneous response [9]. In addition, since SUVmax only involves a single voxel, it is inherently unable to capture intratumor heterogeneity and unable to measure a change in the shape or volume of (the metabolically active part of) the tumor. In recent years, various advanced quantitative imaging features, so-called radiomic features, have been proposed and investigated for their potential to quantify tracer uptake, tracer uptake heterogeneity, and/or (metabolically active) tumor geometry [9-21]. The term radiomics refers to studies that extract a large amount of advanced quantitative imaging features from medical imaging studies, e.g., PET/CT studies, as a basis for characterizing a specific aspect of patient health [22-24]. Several challenges have been identified that need to be addressed before radiomic features can be used in clinical practice, including the standardization and robustness of selected features [21]. For standardization, it is of utmost importance to identify which radiomic features are sensitive to a change in reconstruction settings [25-27] or to a change in delineation [11, 26]. For instance, radiomic features that can characterize tracer uptake heterogeneity may treat both partial volume effects and noise as heterogeneity [9]. Although it has been shown that several radiomic features are not sensitive to partial volume effects and noise when extracted from PET/CT response data of esophageal carcinoma patients [26], it has been shown that some features do require image denoising and partial volume correction prior to extraction [9, 26]. Recently, two studies [25, 27] investigated the effects of different reconstruction settings on the values obtained from various texture-based features and indicated a need for standardization. Note that for response monitoring studies, it is important to know whether an observed change in tracer uptake, tumor geometry, or tracer uptake heterogeneity is due to a true response or methodological variation (i.e., biological, technical, or observer variability). Therefore, it is essential to assess the repeatability of these radiomic features. However, to the best of our knowledge, the effects of reconstruction and delineation on the repeatability of a large set of radiomic features, including intensity-, shape-, and texture-based features, have not yet been assessed. Therefore, the aim of this study was to assess the repeatability of various radiomic features in NSCLC [18F]FDG-PET/CT studies, taking different reconstruction settings and delineation methods into account. To assess the impact of different reconstruction settings, PET data were reconstructed twice using settings that either ensure harmonization (i.e., complied with the European Association of Nuclear Medicine (EANM) guidelines for tumor PET imaging [28]) or are more state of the art (i.e., use of a resolution model during image reconstruction). To assess the impact of delineation, volumes of interest (VOIs) were defined manually on (low-dose) CT images and semi-automatically on PET images. CT-based delineation was explored to illustrate the effects when using the anatomical volume of a tumor, thereby potentially capturing a higher level of tracer uptake heterogeneity within a VOI (e.g., by the inclusion of necrotic areas) compared to semi-automatic threshold-based isocontour methods on PET data.

Materials and Methods

Patient Data

Eleven NSCLC patients (Table 1) received double-baseline whole-body [18F]FDG scans that were acquired on a time-of-flight (TOF) PET/CT scanner (Philips Healthcare, Cleveland, OH). The time interval between first and second baseline scans was less than 3 days (1.3 ± 0.5 days). This prospective study has been approved by the institutional review board and is part of a study that has been registered in the Dutch trial register (www.trialregister.nl; NTR3508). Informed consent was obtained from all individual participants included in the study. Patients were included if they were 18 years or older, were diagnosed with stage IIIB or IV of NSCLC, had at least one lesion with a diameter larger than 3 cm, and were able to remain supine for 60 min during acquisition. Patients were excluded if they were pregnant or lactating, had chemotherapy in the past 4 weeks, metal implants, a body weight of more than 100 kg, or known diabetes mellitus type I or II.
Table 1

Patient demographics

ParameterValue
Gender
 Male7
 Female4
Age (year)
 Median61
 Range45–66
Weight (kg)
 Median76
 Range57–114
Stage
 III B4
 IV7
Histology
 Adenocarcinoma8
 Squamous cell carcinoma3
Type of lesion
 Primary6
 Metastasis13
Localization
 Lung5
 Mediastinum8
 Hilum2
 Clavicular region4
Lesion volume (ml)
 Median39
 Range18–702
Patient demographics

Acquisition, Reconstruction, and Post-Processing

A static whole-body emission scan was started 1 h (61 ± 2 min) after injection of [18F]FDG (263 ± 61 MBq). Prior to this emission scan, a low-dose CT scan (120 kVp, 50 mAs) was acquired during normal breathing. All PET data were normalized and corrected for scatter and random events, dead time, attenuation, and decay and reconstructed twice using vendor-recommended reconstruction settings. All reconstruction settings utilize a blob-based TOF list-mode-ordered subset expectation maximization algorithm with 3 iterations and 33 subsets [29]. The first reconstruction setting applied an additional Gaussian filter in order to comply with the EANM guidelines for tumor PET imaging [28]. The second reconstruction setting applied an additional post-reconstruction resolution recovery method, i.e., a maximum likelihood expectation maximization deconvolution [30] that uses the spatially variant point spread function (PSF) of the system, as implemented by the PET/CT vendor. All resulting PET images have a matrix size of 144 × 144 voxels with a voxel size of 4 × 4 × 4 mm. After reconstruction, PET image data were expressed in SUV by normalizing voxel radioactivity concentrations [kBq · ml−1] to injected dose of [18F]FDG [MBq] and the patient’s body weight (kg). All CT images have a matrix size of 512 × 512 voxels with a voxel size of 1.2 × 1.2 × 5 mm and were rescaled to the dimensions of the PET images prior to delineation. In this way, voxel tissue fraction effects within the delineations are avoided and calculations are performed using the original non-rebinned PET images, as recommended by Uniform Protocols for Imaging in Clinical Trials (UPICT) working group [31].

Delineation

Nineteen VOIs were delineated for lesions larger than 10 ml on both PET and low-dose CT images. CT-based VOIs were drawn manually upon consensus between an experienced physician, a physician in training, and a medical physic expert, using the medical history and previously acquired contrast-enhanced CT images as prior knowledge. PET-based VOIs were drawn semi-automatically by using an isocontour method that applies a threshold of 50 % of the 3D peak SUV (SUVpeak, obtained using a sphere of 12-mm diameter) corrected for local background [12]. PET-based VOIs were drawn twice, i.e., both on PSF-based and EANM-compliant images.

Radiomic Features

For each VOI, 105 radiomic features were determined. These features can be divided into the following three groups (Table 2): intensity (n = 27), shape (n = 9), and texture (n = 69). The textural features were based on fractals, grey-level co-occurrence matrices (GLCMs), or grey-level run-length matrices (GLRMs). Features derived from GLCM and GLRM were calculated by averaging the obtained values over 13 symmetric directions in three dimensions [11]. For those features that require SUV discretization (i.e., resampling of the image intensity values), two types of discretization were used [21], 64 grey-level bins [14, 18] or a fixed bin size of 0.25 g/ml [21]. A fixed bin size of 0.25 g/ml represents the mean SUVmax for all 19 lesions (18 and 14 g/ml when obtained from PSF-based and EANM-compliant images, respectively) divided by 64 bins.
Table 2

Implemented radiomic features with corresponding literature references describing the features

GroupNo. of featuresNames of radiomic featuresDescribed in
Intensity27Maximum standardized uptake value (SUVmax), mean SUV (SUVmean), mean SUV of a sphere of 12-mm diameter (SUVpeak), coefficient of variation (COV), total lesion glycolysis (TLG), mean SUV of maximum SUV and the six adjacent voxels (SUVstar), minimum SUV (SUVmin), range of SUV (SUVrange), median SUV (SUVmedian), standard deviation (SD), skewness, kurtosis, mean absolute deviation, median absolute deviation, mean Laplacian, total energy, variance, root-mean-square (RMS), Moran’s I, Geary’s C, uniformitya, entropya, local entropya, and area under a cumulative (AUC) SUV-volume histogram[914]
Shape9Compactness A, compactness B, sphericity, disproportion, surface area, metabolically active tumor volume (MATV) or anatomical volume (AV), surface to volume ratio (S2V), surface of an equivolumetric sphere to volume ratio (S2Veq), and radius of an equivolumetric sphere[11]
Texture69Based on fractals (n = 3): fractal dimension (FD), abundance, and lacunarity;Based on grey-level co-occurrence matricesa (n = 44): autocorrelation, cluster prominence, cluster shade, cluster tendency, contrast, correlation, difference entropy, dissimilarity, energy, entropy, homogeneity 1, homogeneity 2, informational measure of correlation 1 (IMC1), IMC2, inverse difference moment normalized (IDMN), inverse difference normalized (IDN), inverse variance, maximum probability, sum average, sum entropy, sum variance, and variance;Based on grey-level run-length matricesa (n = 22): grey-level non-uniformity (GLN), high-grey-level run emphasis (HGLRE), long-run emphasis (LRE), long-run high-grey-level emphasis (LRHGLE), long-run low-grey-level emphasis (LRLGLE), low-grey-level run emphasis (LGLRE), run length non-uniformity (RLN), run percentage (RP), short-run emphasis (SRE), short-run high-grey-level emphasis (SRHGLE), and short-run low-grey-level emphasis (SRLGLE)[11, 15, 16]

aTwo types of SUV discretization were used, 64 grey-level bins or a fixed bin size of 0.25 g/ml

Implemented radiomic features with corresponding literature references describing the features aTwo types of SUV discretization were used, 64 grey-level bins or a fixed bin size of 0.25 g/ml

Statistics

To assess the level of repeatability, mean relative test-retest variability (TRT, in %) was calculated for all 105 radiomic features by Eq. (1).where n is the number of lesions. In addition, mean absolute TRT (TRT, in %) was calculated by TRT = |TRT|. A TRT closer to zero indicates a higher level of repeatability. In addition, intraclass correlation coefficients (ICCs) were calculated between the values obtained from first and second baseline scans using a one-way random single-measure model (Real Statistics Resource Pack release 3.5; www.real-statistics.com). ICC does not only take the variance within subjects but also variance between subjects into account. An ICC of 1 indicates perfect reliability. For both TRT and ICC, 95 % confidence intervals were calculated. A related-sample Wilcoxon signed-rank test was applied to ICC, TRT, and TRT of all features to assess whether a change in reconstruction setting or delineation significantly changed ICC, TRT, or TRT. P values less than 0.05 were considered significant. A threshold of 0.90 for ICC was used to group features into sets of features showing an overall good, variable, or overall poor performance. This threshold is in line with the ICC found in literature for SUVmax [11, 13, 14]. An overall good performance means that all four possible combinations of delineation and reconstruction algorithm resulted in an ICC ≥ 0.90, whereas a variable performance means that at least one but not all combinations resulted in an ICC ≥ 0.90. An overall poor performance indicates that all combinations resulted in an ICC < 0.90. Features were considered to be sensitive to an applied delineation and/or selected reconstruction algorithm when the absolute change in ICC was at least 0.03. For these features, the best performing delineation and/or reconstruction algorithm was determined.

Results

Most intensity-, shape-, and texture-based features (98 %) have a repeatability that is comparable to those seen for simple SUV measures in literature (e.g., SUVmax, SUVmean, and SUVpeak) (Supplemental Tables 1 to 12). When compared to the ICC of SUVmean observed in this study, 37 % of the features showed an equal or better ICC for at least one combination of delineation and reconstruction, while 12 % of the features showed an equal or better ICC independent of delineation and reconstruction. Figure 1 shows a typical example where the various reconstruction settings and image types (e.g., functional or anatomical) resulted in different VOI. A small but significant improvement in median ICC was observed for features extracted using CT-based delineation compared to those extracted using PET-based delineation independent of the applied reconstruction setting (from 0.960 to 0.962 and from 0.953 to 0.962 for EANM-compliant and PSF-based images, respectively; Fig. 2). This is also reflected in a decrease in the number of outliers and extreme cases (Table 3), derived from the box plots (Fig. 2). In addition, a small but significant improvement in median ICC was observed for features extracted using EANM-compliant reconstruction with CT-based delineation compared to those extracted using PSF-based reconstruction with PET-based delineation (from 0.953 to 0.962). All other differences in median ICC were insignificant.
Fig. 1

Axial (left) and sagittal (right) PET/CT images of a typical NSCLC patient with (visually) rather heterogeneous [18F] FDG uptake in the primary lung tumour. The black contours illustrate the various (CT- or PET-based) delineations. Rigid co-registration was applied for illustration purposes only to co-register the second baseline scan onto the first baseline scan using VINCI v4.23 (Max-Planck-Institute for Neurological Research, Cologne, Germany) (Color figure online).

Fig. 2

Box plots of a ICC, b TRT, and c TRT of radiomic features extracted from EANM-compliant reconstruction with (I) PET-based or (III) CT-based delineation or PSF-based reconstruction using (II) PET-based or (IV) CT-based delineation. Circles illustrate outliers, and stars illustrate extreme cases. A bar indicates a statistically significant difference (p value < 0.05).

Table 3

Outliers and extreme cases of radiomic features extracted from EANM-compliant or PSF-based reconstructed PET images using PET-based or CT-based delineation

DelineationReconstructionICCTRTr TRTa
OutliersExtreme casesOutliersExtreme casesOutliersExtreme cases
PET-basedEANM-compliantAUCFD and homogeneities 1 and 2 (64B)VarianceCluster shade (64B and FB) and cluster prominence (64B)Cluster prominence (64B and FB) and cluster shade (FB)
PSF-basedFD and contrast (64B)AUCVariance, variance (FB), sum variance (FB), and autocorrelation (FB)Skewness, cluster shade (FB), and cluster tendency (FB)Skewness and cluster prominence (FB)Cluster shade (64B and FB) and correlation (64B and FB)
CT-basedEANM-compliantSRE and compactness AAUCSkewness, cluster shade (64B), autocorrelation (FB), cluster tendency (FB), contrast (FB), and sum variance (FB)Cluster shade (FB) and cluster prominence (FB)Skewness, cluster prominence (FB), and cluster shade (64B and FB)
PSF-basedSkewness, autocorrelation (FB), contrast (FB), and sum variance (FB)Cluster shade (FB) and cluster prominence (FB)Cluster prominence (FB)Skewness and cluster shade (FB)

Two types of SUV discretization were used, 64 grey-level bins (64B) or a fixed bin size of 0.25 g/ml (FB)

Axial (left) and sagittal (right) PET/CT images of a typical NSCLC patient with (visually) rather heterogeneous [18F] FDG uptake in the primary lung tumour. The black contours illustrate the various (CT- or PET-based) delineations. Rigid co-registration was applied for illustration purposes only to co-register the second baseline scan onto the first baseline scan using VINCI v4.23 (Max-Planck-Institute for Neurological Research, Cologne, Germany) (Color figure online). Box plots of a ICC, b TRT, and c TRT of radiomic features extracted from EANM-compliant reconstruction with (I) PET-based or (III) CT-based delineation or PSF-based reconstruction using (II) PET-based or (IV) CT-based delineation. Circles illustrate outliers, and stars illustrate extreme cases. A bar indicates a statistically significant difference (p value < 0.05). Outliers and extreme cases of radiomic features extracted from EANM-compliant or PSF-based reconstructed PET images using PET-based or CT-based delineation Two types of SUV discretization were used, 64 grey-level bins (64B) or a fixed bin size of 0.25 g/ml (FB) Sixty three out of 105 radiomic features showed a good performance (i.e., ICC ≥ 0.9) independent of the applied delineation or selected reconstruction algorithm, while 40 features only showed a good performance for certain combinations of reconstruction algorithm and/or delineation (Fig. 3a). More features were sensitive to a change in delineation than to a change in reconstruction (25 and 3 features, respectively), and 25 features were sensitive to a change in both reconstruction and delineation. Only fractal dimension and homogeneity 2 (obtained using 64 grey-level bins) showed an overall poor performance. After excluding these two features, the majority of the features showed less than 0.03 difference in ICC for either applied delineation and/or reconstruction (49 %; Fig. 4a). The best performance was seen using CT-based delineation (32 %), followed by EANM-compliant reconstruction or PET-based delineation (both 17 %), and PSF-based reconstruction (10 %).
Fig. 3

Performance of radiomic features extracted from EANM-compliant or PSF-based reconstructed PET images using PET-based or CT-based delineation. Performance is given for a all features; b intensity-based, shape-based, and texture-based features; c GLCM-based and GLRM-based features using 64 grey-level bins; and d GLCM-based and GLRM-based features using fixed bins.

Fig. 4

Combinations of delineation and reconstruction showing the best performance, given for a all features; b intensity-based, shape-based, and texture-based features; c GLCM-based and GLRM-based features using 64 grey-level bins; and d GLCM-based and GLRM-based features using fixed bins. Features that showed a poor performance were not included.

Performance of radiomic features extracted from EANM-compliant or PSF-based reconstructed PET images using PET-based or CT-based delineation. Performance is given for a all features; b intensity-based, shape-based, and texture-based features; c GLCM-based and GLRM-based features using 64 grey-level bins; and d GLCM-based and GLRM-based features using fixed bins. Combinations of delineation and reconstruction showing the best performance, given for a all features; b intensity-based, shape-based, and texture-based features; c GLCM-based and GLRM-based features using 64 grey-level bins; and d GLCM-based and GLRM-based features using fixed bins. Features that showed a poor performance were not included. More than two thirds of the intensity-based features (70 %) and one third of shape-based and texture-based features show an overall good performance (56 and 57 %, respectively; Fig. 3b). After excluding the features with an overall poor performance, most intensity-based features had a less than 0.03 difference in ICC for either applied delineation and/or reconstruction (70 %). Most shape-based features showed the best performance using PET-based delineation (56 %), while most texture-based features showed the best performance using CT-based delineation (39 %; Fig. 4b). The percentages of both GLCM-based and GLRM-based features showing an overall good performance increased when fixed bins were applied compared to 64 grey-level bins (55 and 100 % vs 36 and 63 %, respectively; Fig. 3c, d). After excluding those features showing an overall poor performance, most features showed less than 0.03 difference in ICC for either applied delineation and/or reconstruction, except for GLCM-based features when 64 grey-level bins were applied, showing the best performance using CT-based delineation (62 %; Fig. 4c).

Discussion

The present study shows that the majority of radiomic features show a high level of repeatability that is similar or better compared to simple SUV measures such as SUVmean in terms of ICC, TRT, and TRT [12, 32]. These results are in line with three previous studies by Leijenaar et al. [11], Tixier et al. [14], and Van Velden et al. [13], investigating the repeatability of various radiomic features in NSCLC patients, esophageal cancer patients, and patients with colorectal liver metastases, respectively. Data presented in these studies and the present study enable a preselection of well-performing features per category in order to further assess them for their clinical applicability. To the best of our knowledge, this is the first study that investigates the impact of various reconstructions and delineations on the repeatability of several radiomic features, including intensity-, shape-, and texture-based features. However, this is not the first study that investigates the impact of reconstruction and delineation on radiomic features. A previous study by Hatt et al. [26] investigated the impact of reconstruction-based partial volume correction and various PET-based delineation on radiomic features in terms of therapy response prediction for esophageal cancer patients, showing that the performance of radiomic features were more dependent on delineation than on partial volume correction (i.e., reconstruction settings). Two studies [25, 27] investigated the effects of different reconstruction settings on the values obtained from various texture-based features. Galavis et al. [25] found that most features (80 %) showed a large variation between values (>30 %) when reconstruction settings were varied. Yan et al. [27] showed that 5 to 56 % of the features showed a large variation between values (>20 %) when reconstruction settings were varied and that zone percentage, cluster shade, and skewness should be used with caution. The level of features sensitive to the reconstruction settings is expected to be different in the present study, as the present study does not investigate differences between values obtained from features extracted from PSF-based and EANM-compliant reconstructed images but investigates whether or not they show repeatable results. Note that thresholds used in this study are arbitrary and only intended to illustrate which features are sensitive to delineation and/or reconstruction. Nonetheless, our study confirmed that many texture-based features (36 %) were sensitive to the selected reconstruction algorithm by showing a change in repeatability (i.e., showing a more than 3 % difference in ICC). In addition, we observed a large variation in repeatability for skewness and cluster shade when reconstruction settings were varied. Recently, Leijenaar et al. [21] investigated the effects of SUV discretizations on radiomic features and concluded that the manner of SUV discretization (i.e., fixed bin size in units of SUV or a fixed number of bins) had a crucial impact on the values of various texture-based radiomic features and the interpretation thereof. They suggest that using a fixed bin size in units of SUV is more appropriate in a clinical response monitoring setting as it can incorporate changes in SUV due to a course of treatment. Our present study shows that using a fixed bin size in units of SUV results in texture-based features that show a better repeatability and a lower sensitivity to a change in delineation and/or reconstruction compared to using a fixed number of bins. A previous study [14] showed that 64 grey-level bins are best suited for extraction of radiomic features when a fixed number of bins is applied. This would, on average, translate to 0.25 g/ml for the lesions in the present study. However, a fixed bin size of 0.5 g/ml has been applied in a previous publication [11], but no further motivation is provided. A clinical study that includes outcome measures is required to validate which fixed bin size is optimal in a clinical setting. Nevertheless, this study confirms that, if a fixed bin size is best suited for clinical response monitoring, a standardized methodology in texture analysis is needed to compare results in a multicenter setting, i.e., by standardization of reconstruction settings, delineations, and SUV discretization [18, 21, 33]. A limitation of this study is that the CT-based delineation is obtained manually. Therefore, these results may to a small extent be affected by inter-observer variability [11, 34]. Ideally, the effects of inter-observer variability on our results should be assessed by manual CT delineation by three observers. In this study, we aimed to minimize the impact of inter-observer variability by achieving consensus by means of discussion between three experienced observers.

Conclusion

In this paper, we report on the repeatability of radiomic features for NSCLC [18F]FDG-PET/CT studies, showing that many features have similar TRT and ICC performance as more commonly used PET parameters, such as SUVmax, SUVmean, and SUVpeak. Furthermore, PSF-based reconstructions do not necessarily result in improved repeatability of radiomic features when compared to EANM-compliant reconstructions. Performance of radiomic features depended more on delineation method than on the applied reconstruction algorithm. CT-based delineation showed favorable repeatabilities and ICCs for most radiomic features, except for shape-based features for which PET-based delineation resulted in better performance in terms of TRT and ICC. Below is the link to the electronic supplementary material. (PDF 255 kb)
  32 in total

1.  Impact of Image Reconstruction Settings on Texture Features in 18F-FDG PET.

Authors:  Jianhua Yan; Jason Lim Chu-Shern; Hoi Yin Loi; Lih Kin Khor; Arvind K Sinha; Swee Tian Quek; Ivan W K Tham; David Townsend
Journal:  J Nucl Med       Date:  2015-07-30       Impact factor: 10.057

2.  Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials.

Authors:  Michael M Graham; Richard L Wahl; John M Hoffman; Jeffrey T Yap; John J Sunderland; Ronald Boellaard; Eric S Perlman; Paul E Kinahan; Paul E Christian; Otto S Hoekstra; Gary S Dorfman
Journal:  J Nucl Med       Date:  2015-04-16       Impact factor: 10.057

3.  Value of metabolic tumor volume on repeated 18F-FDG PET/CT for early prediction of survival in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.

Authors:  Wei Huang; Min Fan; Bo Liu; Zheng Fu; Tao Zhou; Zicheng Zhang; Heyi Gong; Baosheng Li
Journal:  J Nucl Med       Date:  2014-09-11       Impact factor: 10.057

4.  Repeatability of metabolically active tumor volume measurements with FDG PET/CT in advanced gastrointestinal malignancies: a multicenter study.

Authors:  Virginie Frings; Floris H P van Velden; Linda M Velasquez; Wendy Hayes; Peter M van de Ven; Otto S Hoekstra; Ronald Boellaard
Journal:  Radiology       Date:  2014-05-26       Impact factor: 11.105

5.  Response assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non-small cell lung cancer.

Authors:  Wouter van Elmpt; Michel Ollers; Anne-Marie C Dingemans; Philippe Lambin; Dirk De Ruysscher
Journal:  J Nucl Med       Date:  2012-08-09       Impact factor: 10.057

6.  18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort.

Authors:  Mathieu Hatt; Mohamed Majdoub; Martin Vallières; Florent Tixier; Catherine Cheze Le Rest; David Groheux; Elif Hindié; Antoine Martineau; Olivier Pradier; Roland Hustinx; Remy Perdrisot; Remy Guillevin; Issam El Naqa; Dimitris Visvikis
Journal:  J Nucl Med       Date:  2014-12-11       Impact factor: 10.057

7.  Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?

Authors:  Gary J R Cook; Connie Yip; Muhammad Siddique; Vicky Goh; Sugama Chicklore; Arunabha Roy; Paul Marsden; Shahreen Ahmad; David Landau
Journal:  J Nucl Med       Date:  2012-11-30       Impact factor: 10.057

8.  Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.

Authors:  Ronald Boellaard; Nanda C Krak; Otto S Hoekstra; Adriaan A Lammertsma
Journal:  J Nucl Med       Date:  2004-09       Impact factor: 10.057

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis.

Authors:  Ralph T H Leijenaar; Georgi Nalbantov; Sara Carvalho; Wouter J C van Elmpt; Esther G C Troost; Ronald Boellaard; Hugo J W L Aerts; Robert J Gillies; Philippe Lambin
Journal:  Sci Rep       Date:  2015-08-05       Impact factor: 4.379

View more
  90 in total

1.  [18]Fluorodeoxyglucose Positron Emission Tomography for the Textural Features of Cervical Cancer Associated with Lymph Node Metastasis and Histological Type.

Authors:  Wei-Chih Shen; Shang-Wen Chen; Ji-An Liang; Te-Chun Hsieh; Kuo-Yang Yen; Chia-Hung Kao
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-14       Impact factor: 9.236

Review 2.  Towards precision medicine: from quantitative imaging to radiomics.

Authors:  U Rajendra Acharya; Yuki Hagiwara; Vidya K Sudarshan; Wai Yee Chan; Kwan Hoong Ng
Journal:  J Zhejiang Univ Sci B       Date:  2018 Jan.       Impact factor: 3.066

3.  Radiomics in nuclear medicine: robustness, reproducibility, standardization, and how to avoid data analysis traps and replication crisis.

Authors:  Alex Zwanenburg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-25       Impact factor: 9.236

4.  Neural network training for cross-protocol radiomic feature standardization in computed tomography.

Authors:  Vincent Andrearczyk; Adrien Depeursinge; Henning Müller
Journal:  J Med Imaging (Bellingham)       Date:  2019-06-06

5.  Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.

Authors:  Lihong Peng; Xiaotong Hong; Qingyu Yuan; Lijun Lu; Quanshi Wang; Wufan Chen
Journal:  Ann Nucl Med       Date:  2021-02-04       Impact factor: 2.668

Review 6.  Texture analysis of medical images for radiotherapy applications.

Authors:  Elisa Scalco; Giovanna Rizzo
Journal:  Br J Radiol       Date:  2016-11-25       Impact factor: 3.039

7.  The impact of image reconstruction settings on 18F-FDG PET radiomic features: multi-scanner phantom and patient studies.

Authors:  Isaac Shiri; Arman Rahmim; Pardis Ghaffarian; Parham Geramifar; Hamid Abdollahi; Ahmad Bitarafan-Rajabi
Journal:  Eur Radiol       Date:  2017-05-31       Impact factor: 5.315

Review 8.  NCTN Assessment on Current Applications of Radiomics in Oncology.

Authors:  Ke Nie; Hania Al-Hallaq; X Allen Li; Stanley H Benedict; Jason W Sohn; Jean M Moran; Yong Fan; Mi Huang; Michael V Knopp; Jeff M Michalski; James Monroe; Ceferino Obcemea; Christina I Tsien; Timothy Solberg; Jackie Wu; Ping Xia; Ying Xiao; Issam El Naqa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-01-31       Impact factor: 7.038

9.  Radiomics Analysis of PET and CT Components of PET/CT Imaging Integrated with Clinical Parameters: Application to Prognosis for Nasopharyngeal Carcinoma.

Authors:  Wenbing Lv; Qingyu Yuan; Quanshi Wang; Jianhua Ma; Qianjin Feng; Wufan Chen; Arman Rahmim; Lijun Lu
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

10.  Prognostic value of 18F-FDG PET/CT with texture analysis in patients with rectal cancer treated by surgery.

Authors:  Masatoshi Hotta; Ryogo Minamimoto; Yoshimasa Gohda; Kenta Miwa; Kensuke Otani; Tomomichi Kiyomatsu; Hideaki Yano
Journal:  Ann Nucl Med       Date:  2021-05-04       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.